Does NILOTINIB Cause Neoplasm recurrence? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Neoplasm recurrence have been filed in association with NILOTINIB (nilotinib). This represents 0.0% of all adverse event reports for NILOTINIB.
10
Reports of Neoplasm recurrence with NILOTINIB
0.0%
of all NILOTINIB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Neoplasm recurrence From NILOTINIB?
Of the 10 reports, 2 (20.0%) resulted in death, 3 (30.0%) required hospitalization.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which NILOTINIB Alternatives Have Lower Neoplasm recurrence Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB